The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Chylous Ascites in a Patient with Liver Cirrhosis after Subtotal Gastrectomy

간경변 환자에서 위부분절제술 후 발생한 암죽복수 1예

  • Jang, Won-Seok (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Kim, Eun-Young (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Shin, Hyun-Phil (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Jung, Sung-Won (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Cha, Jae-Myung (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Joo, Kwang-Ro (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Lee, Joung-Il (Department of Internal Medicine, Kyung Hee University School of Medicine)
  • 장원석 (경희대학교 의과대학 내과학교실) ;
  • 김은영 (경희대학교 의과대학 내과학교실) ;
  • 신현필 (경희대학교 의과대학 내과학교실) ;
  • 정성원 (경희대학교 의과대학 내과학교실) ;
  • 차재명 (경희대학교 의과대학 내과학교실) ;
  • 주광로 (경희대학교 의과대학 내과학교실) ;
  • 이정일 (경희대학교 의과대학 내과학교실)
  • Published : 2011.04.01
⟨ Previous Next ⟩

Abstract

Chylous ascites is the extravasation of milky chyle into the peritoneal cavity. This condition can occur as a result of the disruption or obstruction of the abdominal lymphatics. Abdominal surgery, malignant neoplasms, and cirrhosis can cause chylous ascites. Here, we report a case of intractable ascites caused by chyle leakage and portal hypertension in a patient with alcoholic liver cirrhosis. The ascites occurred following a subtotal gastrectomy to treat stomach cancer and was not resolved with diuretics. Increasing the diuretic dosage was limited by the aggravation of renal function. The ascites was milky in color and analysis showed transudate caused by portal hypertension. Octreotide and diuretic treatments can resolve mixed ascites. In this article, we present the case and review the literature.

본 저자는 간경변 환자에서 복강경 위부분절제술 후 발생한 이뇨제로 조절 되지 않는 복수를 경험하였고 검사상 수술에 따른 암죽 복수와 간문맥 고혈압으로 인한 복수가 동반된 소견이었다. 이후 저지방식이, 전비경구 영양과 octreotide 병용치료 뒤 암죽복수에서 중성지방 수치 감소하였고 남아있는 간문맥 고혈압에 의한 복수를 이뇨제를 사용하여 조절할 수 있었다. 이후 특별한 재발 없이 호전된 증례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

Keywords

References

  1. Cardenas A, Chopra S. Chylous ascites. Am J Gastroenterol 2002;97:1896-1900. https://doi.org/10.1111/j.1572-0241.2002.05911.x
  2. Cheng WS, Gough IR, Ward M, Croese J, Powell LW. Chylous ascites in cirrhosis: a case report and review of the literature. J Gastroenterol Hepatol 1989;4:95-99. https://doi.org/10.1111/j.1440-1746.1989.tb00811.x
  3. Leibovitch I, Mor Y, Golomb J, Ramon J. The diagnosis and management of postoperative chylous ascites. J Urol 2002;167:449-457. https://doi.org/10.1016/S0022-5347(01)69064-5
  4. Malagelada JR, Iber FL, Linscheer WG. Origin of fat in chylousascites of patients with liver cirrhosis. Gastroenterology 1974;67:878-886.
  5. Wu CW, Hsieh MC, Lo SS, Lui WY, P'eng FK. Results of curative gastrectomy for carcinoma of distal third of the stomach. J Am Coll Surg 1996;183:201-207.
  6. Browse NL, Wilson NM, Russo F, al-Hassan H, Allen DR. Aetiology and treatment of chylous ascites. Br J Surg 1992;79:1145-1150. https://doi.org/10.1002/bjs.1800791110
  7. Press OW, Press NO, Kaufman SD. Evaluation and management of chylous ascites. Ann Intern Med 1982;96:358-364. https://doi.org/10.7326/0003-4819-96-3-358
  8. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988;8:1104-1109. https://doi.org/10.1002/hep.1840080521
  9. Jungst D, Gerbes AL, Martin R, Paumgartner G. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology 1986;6:239-243. https://doi.org/10.1002/hep.1840060214
  10. Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest 2008;133:1436-1441. https://doi.org/10.1378/chest.07-2232
  11. Archimandritis AJ, Zonios DI, Karadima D, Vlachoyiannopoulos PG, Kiriaki D, Hatzis GS. Gross chylous ascites in cirrhosis with massive portal vein thrombosis: diagnostic value of lymphoscintigraphy: a case report and review of the literature. Eur J Gastroenterol Hepatol 2003;15:81-85. https://doi.org/10.1097/00042737-200301000-00014
  12. Diaz-Guzman E, Culver DA, Stoller JK. Transudative chylothorax: report of two cases and review of the literature. Lung 2005;183:169-175. https://doi.org/10.1007/s00408-004-2531-2
  13. Weinstein LD, Scanlon GT, Hersh T. Chylous ascites: management with medium-chain triglycerides and exacerbation by lymphangiography. Am J Dig Dis 1969;14:500-509. https://doi.org/10.1007/BF02283890
  14. Ohri SK, Patel T, Desa LA, Spencer J. The management of postoperative chylous ascites: a case report and literature review. J Clin Gastroenterol 1990;12:693-697. https://doi.org/10.1097/00004836-199012000-00021
  15. Ijichi H, Soejima Y, Taketomi A, et al. Successful management of chylous ascites after living donor liver transplantation with somatostatin. Liver Int 2008;28:143-145.
  16. Rosti L, De Battisti F, Butera G, et al. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 2005;26:440-443. https://doi.org/10.1007/s00246-004-0820-4
  17. Rector WG Jr. Spontaneous chylous ascites of cirrhosis. J Clin Gastroenterol 1984;6:369-372.
  18. Berzigotti A, Magalotti D, Cocci C, et al. Octerotide in the outpatient therapy of cirrhotic chylous ascites: a case report. Dig Liver Dis 2006;38:138-142.
  19. Roehr CC, Jung A, Proquitté H, et al. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med 2006;32:650-657. https://doi.org/10.1007/s00134-006-0114-9
  20. Bhatia C, Pratap U, Slavik Z. Octreotide therapy: a new horizon in treatment of iatrogenic chyloperitoneum. Arch Dis Child 2001;85:234-235. https://doi.org/10.1136/adc.85.3.234